Ankylosing spondylitis trials in Canada

3 of 4 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis

  Where

  Calgary, Montreal, Saskatoon

  Age

  2 years to 18 years

  People

  40 worldwide

  Run by

  UCB Biopharma SRL

  See details and how to joinNCT06668181 · EU 2023-508845-41-00
• Phase 1Taking people
  A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

  Where

  Calgary, Vancouver

  Age

  18 years and over

  People

  20 worldwide

  Run by

  UCB Biopharma SRL

  See details and how to joinNCT06888193 · EU 2024-518689-29-00
• Phase 4Taking people
  A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis

  Where

  Ottawa, Québec

  Age

  18 years and over

  People

  100 worldwide

  Run by

  CARE ARTHRITIS LTD.

  See details and how to joinNCT06454188 · EU 2023-510242-24-00